Brief: Rua Bioscience Says Sales For Q1 FY26 Are A Record
02/11/2025 20:09
Nov 3 (Reuters) - Rua Bioscience RUA.NZ: SALES FOR Q1 FY26 ARE A RECORD RENOUCENABLE RIGHTS ISSUE OF 1 NEW SHARES FOR EVERY 3 EXISTING SHARES TO RAISE UP TO NZ$2MILLION ISSUE PRICE UNDER RIGHTS OFFER NZ$0.025 PER SHARE Further company coverage: RUA.NZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Reports Research Partnership To Develop Smoking Cessation Products
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising